Short-term omalizumab treatment in an adolescent with cutaneous mastocytosis

Ann Allergy Asthma Immunol. 2013 Nov;111(5):425-6. doi: 10.1016/j.anai.2013.08.014. Epub 2013 Sep 21.

Authors

Almudena Matito¹, Cristina Blázquez-Goñi, Jose M Morgado, Iván Alvarez-Twose, Manuela Mollejo, Laura Sánchez-Muñoz, Luis Escribano

Affiliation

¹ Instituto de Estudios de Mastocitosis de Castilla La Mancha, Toledo, Spain. Electronic address: amatito@sescam.jccm.es.

PMID: 24125156
DOI: 10.1016/j.anai.2013.08.014

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adolescent
Animals
Anti-Allergic Agents / therapeutic use*
Antibodies, Anti-Idiotypic / therapeutic use*
Antibodies, Monoclonal, Humanized / therapeutic use*
Asthma / drug therapy
Asthma / immunology
Female
Humans
Mastocytosis, Cutaneous / drug therapy*
Omalizumab
Pyroglyphidae / immunology

Substances

Anti-Allergic Agents
Antibodies, Anti-Idiotypic
Antibodies, Monoclonal, Humanized
Omalizumab